Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal for ImmunoTherapy of Cancer

Topics

Medicine

Cancer Oncology

Epidemiology

Immunology

Internal Medicine

Show all topics

DOI

10.1136/jitc-2024-010827

License

CC-BY-NC-ND